US Representative

Vince Fong 2025-2026 Regular Session - Authored & Sponsored Legislation (Page 3)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB4662

Introduced
7/23/25  
To designate the facility of the United States Postal Service located at 6444 San Fernando Road in Glendale, California, as the "Paul Ignatius Post Office".
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB471

Introduced
1/16/25  
Refer
1/16/25  
Fix Our Forests Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB521

Introduced
1/16/25  
Ending Presidential Overreach on Public Lands Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB551

Introduced
1/16/25  
Make the Migrant Protection Protocols Mandatory Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB685

Introduced
1/23/25  
Support And Value Expectant Moms and Babies Act of 2025 or the SAVE Moms and Babies Act of 2025This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved.Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner.The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient.The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB689

Introduced
1/23/25  
Refer
1/23/25  
FREE Act Full Responsibility and Expedited Enforcement Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB7

Introduced
1/22/25  
No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB703

Introduced
1/23/25  
Main Street Tax Certainty Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB817

Introduced
1/28/25  
Educational Choice for Children Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB821

Introduced
1/28/25  
Fred Korematsu Congressional Gold Medal Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB833

Introduced
1/31/25  
Educational Choice for Children Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB842

Introduced
1/31/25  
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB909

Introduced
2/4/25  
Crime Victims Fund Stabilization Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HJR28

Introduced
1/22/25  
Proposing an amendment to the Constitution of the United States to require that the Supreme Court of the United States be composed of nine justices.

Primary Sponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB477

Introduced
1/16/25  
Making Advancements in Commercial Hypersonics Act or the MACH ActThis bill permits the National Aeronautics and Space Administration (NASA) to establish a research program to facilitate the testing of high-speed aircraft and related technologies, to be known as the Making Advancements in Commercial Hypersonics Program.Within a specified time period, NASA must develop a strategic plan for such research. NASA must also consult with the Department of Defense and the Federal Aviation Administration on these efforts. Under the program, NASA may not (1) fund the development of hypersonic and related technologies; or (2) enter into an agreement with certain foreign entities of concern, including entities owned or controlled by China, Iran, North Korea, or Russia.